Research

Mixed

Genetic ablation of senescent cells using the INK-ATTAC transgenic system delays age-related phenotypes and extends lifespan in mice.

This is a foundational scientific finding showing that removing senescent cells can extend life in mice. It provides the biological rationale for developing drugs (senolytics) to do the same in humans, but the genetic method itself is not a human intervention.

ModerateSupportsMEDIUM confidence
The authors demonstrated that the animals treated with AP20187 from early (weaning time) or late (5 months) in life, had reduced numbers of p16Ink4a-positive senescent cells, and progression of p16Ink4a-mediated age-related phenotypes in adipose tissue and muscle was delayed (19).
Eok-Cheon Kim et al. · BMB Reports · 2019

Why this rating

Based on transgenic mouse models; highly controlled but not translatable directly to humans without significant modification.

Source

Senotherapeutics: emerging strategy for healthy aging and age-related disease

Eok-Cheon Kim et al. · BMB Reports · 2019

DOI 10.5483/bmbrep.2019.52.1.293

narrative_reviewCited 199×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →